• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

17
1
1
1

COUNTRY

1

CATEGORIES

  • 21
  • 18
  • 11
  • 7
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

28
30
43
60

PUBLISHED

7
12
17
60

PRODUCT TYPE

31
29

Search "Cephalon Inc-Detailed Product Pipeline" returned 60 results.

Cephalon, Inc. - Product Pipeline Review - 2012 Cephalon, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Cephalon, Inc. - Product Pipeline Review - 2012

Cephalon, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Cephalon, Inc. - Product Pipeline Review - 2012” provides data on the Cephalon, Inc.’s research...

September 2012
FROM
Cephalon, Inc. - Product Pipeline Review - H2 2011 Cephalon, Inc. - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Cephalon, Inc. - Product Pipeline Review - H2 2011

Cephalon, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Cephalon, Inc. - Product Pipeline Review - H2 2011” provides data on the Cephalon, Inc.’s...

November 2011
FROM
Cephalon, Inc. - Product Pipeline Review - Q4 2010 Cephalon, Inc. - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Cephalon, Inc. - Product Pipeline Review - Q4 2010

Cephalon, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Cephalon, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM
Cephalon, Inc. - Strategic SWOT Analysis Review Cephalon, Inc. - Strategic SWOT Analysis Review - Product Thumbnail Image

Cephalon, Inc. - Strategic SWOT Analysis Review

Cephalon, Inc. - Strategic SWOT Analysis Review Summary Cephalon, Inc. (Cephalon) is a biopharmaceutical company recently acquired by Teva Pharmaceutical Industries Ltd. focuses on the research, development...

September 2012
FROM

Cephalon, Inc. - Product Pipeline Review - Q4 2010

Cephalon, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Cephalon, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Pharmaceutical Products of the Future: 50-Company Pipeline Analysis to 2015

What Will The Pharmaceutical Market Look Like in the Next Five Years? In this report, Kalorama has analyzed the late stage R&D pipeline of the 50 top companies in pharmaceuticals -- the companies...

July 2010
FROM
Cephalon, Inc. (CEPH) - Financial and Strategic SWOT Analysis Review Cephalon, Inc. (CEPH) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Cephalon, Inc. (CEPH) - Financial and Strategic SWOT Analysis Review

Cephalon, Inc. (CEPH) - Financial and Strategic SWOT Analysis Review Summary Cephalon, Inc. (Cephalon) is a biopharmaceutical company engaged in the research, development and marketing of innovative...

April 2011
FROM

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances,...

June 2014
FROM

Eosinophilic Esophagitis - Pipeline Review, H1 2014

Eosinophilic Esophagitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Eosinophilic Esophagitis - Pipeline Review, H1 2014’, provides an overview of the Eosinophilic Esophagitis’s therapeutic...

April 2014
FROM

Global Diabetic Neuropathy Market 2014-2018

About Diabetic Neuropathy Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized...

May 2014
FROM

Eosinophilic Esophagitis - Pipeline Review, H1 2015

Eosinophilic Esophagitis - Pipeline Review, H1 2015 Summary This, ‘Eosinophilic Esophagitis - Pipeline Review, H1 2015’, provides an overview of the Eosinophilic Esophagitis’s therapeutic pipeline. This...

April 2015
FROM

Eosinophilic Esophagitis - Pipeline Review, H2 2014

Eosinophilic Esophagitis - Pipeline Review, H2 2014 Summary This, ‘Eosinophilic Esophagitis - Pipeline Review, H2 2014’, provides an overview of the Eosinophilic Esophagitis’s therapeutic pipeline. This...

September 2014
FROM

Cancer Pain - Pipeline Review, H1 2014

Cancer Pain - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cancer Pain - Pipeline Review, H1 2014’, provides an overview of the Cancer Pain’s therapeutic pipeline. This report provides...

March 2014
FROM
Celator Pharmaceuticals, Inc. - Product Pipeline Review - 2012 Celator Pharmaceuticals, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Celator Pharmaceuticals, Inc. - Product Pipeline Review - 2012

Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Celator Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data...

July 2012
FROM

Contact Dermatitis - Pipeline Review, H1 2014

Contact Dermatitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Contact Dermatitis - Pipeline Review, H1 2014’, provides an overview of the Contact Dermatitis’s therapeutic pipeline. This...

May 2014
FROM

Contact Dermatitis - Pipeline Review, H2 2014

Contact Dermatitis - Pipeline Review, H2 2014 Summary This, ‘Contact Dermatitis - Pipeline Review, H2 2014’, provides an overview of the Contact Dermatitis’s therapeutic pipeline. This report provides...

October 2014
FROM
Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

July 2015
FROM
Partial Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Partial Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Partial Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Partial Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

July 2015
FROM

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

March 2015
FROM
Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

July 2015
FROM
Loading Indicator

Our Clients

Credit Suisse Group Heinz Company Telenor Group Deutsche Bank AG Solvay S.A. APC by Schneider Electric Lindt & Sprüngli AG